These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38531168)
61. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice. Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245 [TBL] [Abstract][Full Text] [Related]
62. Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism. Huang X; Chen Q; Fan Y; Yang R; Gong G; Yan C; Song Y; Zhang B; Xi S; Huang Y; Xu H Biomed Pharmacother; 2023 Mar; 159():114300. PubMed ID: 36696803 [TBL] [Abstract][Full Text] [Related]
63. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice. Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440 [TBL] [Abstract][Full Text] [Related]
64. Folic acid attenuates high-fat diet-induced steatohepatitis Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787 [TBL] [Abstract][Full Text] [Related]
65. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice. Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452 [TBL] [Abstract][Full Text] [Related]
66. Hepatoprotective Effects of Jin W; Cho S; Laxi N; Bao T; Dai L; Yu H; Qi R; Zhang J; Ba G; Fu M Molecules; 2022 May; 27(10):. PubMed ID: 35630624 [No Abstract] [Full Text] [Related]
67. Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE Ma Y; Chen K; Lv L; Wu S; Guo Z Biomed Pharmacother; 2019 May; 113():108753. PubMed ID: 30856537 [TBL] [Abstract][Full Text] [Related]
68. Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease. Kong CY; Li ZM; Han B; Zhang ZY; Chen HL; Zhang SL; Xu JQ; Mao YQ; Zhao YP; Wang LS Mol Nutr Food Res; 2019 Oct; 63(19):e1900249. PubMed ID: 31271251 [TBL] [Abstract][Full Text] [Related]
69. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192 [TBL] [Abstract][Full Text] [Related]
70. High-protein compound yogurt with quinoa improved clinical features and metabolism of high-fat diet-induced nonalcoholic fatty liver disease in mice. Shi L; Tianqi F; Zhang C; Deng X; Zhou Y; Wang J; Wang L J Dairy Sci; 2023 Aug; 106(8):5309-5327. PubMed ID: 37474360 [TBL] [Abstract][Full Text] [Related]
71. Green Tea Polyphenols Modulate Colonic Microbiota Diversity and Lipid Metabolism in High-Fat Diet Treated HFA Mice. Wang L; Zeng B; Liu Z; Liao Z; Zhong Q; Gu L; Wei H; Fang X J Food Sci; 2018 Mar; 83(3):864-873. PubMed ID: 29427445 [TBL] [Abstract][Full Text] [Related]
72. Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice. Yang M; Wang H; Bukhari I; Zhao Y; Huang H; Yu Y; Sun X; Mi Y; Mei L; Zheng P Front Nutr; 2023; 10():1121203. PubMed ID: 37545590 [TBL] [Abstract][Full Text] [Related]
73. Postbiotics Prepared Using Pan Z; Mao B; Zhang Q; Tang X; Yang B; Zhao J; Cui S; Zhang H Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362307 [TBL] [Abstract][Full Text] [Related]
74. Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. Lee NY; Shin MJ; Youn GS; Yoon SJ; Choi YR; Kim HS; Gupta H; Han SH; Kim BK; Lee DY; Park TS; Sung H; Kim BY; Suk KT Clin Mol Hepatol; 2021 Jan; 27(1):110-124. PubMed ID: 33317254 [TBL] [Abstract][Full Text] [Related]
75. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646 [TBL] [Abstract][Full Text] [Related]
76. Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism. Dong X; Xiong YT; He T; Zheng C; Li J; Zhuang Y; Xu Y; Xiu Y; Wu Z; Zhao X; Xiao X; Bai Z; Gao L Genes Nutr; 2024 Aug; 19(1):17. PubMed ID: 39182019 [TBL] [Abstract][Full Text] [Related]
77. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease]. Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329 [No Abstract] [Full Text] [Related]
78. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797 [TBL] [Abstract][Full Text] [Related]
79. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402 [TBL] [Abstract][Full Text] [Related]
80. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice. Bao T; He F; Zhang X; Zhu L; Wang Z; Lu H; Wang T; Li Y; Yang S; Wang H Front Pharmacol; 2020; 11():558525. PubMed ID: 33390939 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]